This inventor holds 3 USPTO granted patents. Top assignee: The General Hospital Corporation. Active years: 2001-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001-2008
Title: Innovations by Jason Morris
Introduction
Jason Morris is an accomplished inventor based in New York, NY (US). He has made significant contributions to the field of therapeutic and diagnostic tools, particularly in relation to impaired glucose tolerance conditions. With a total of 3 patents, his work has the potential to impact many lives.
Latest Patents
One of his latest patents focuses on therapeutic and diagnostic tools for impaired glucose tolerance conditions. This patent discloses novel genes and methods for screening therapeutics that are useful for treating these conditions, as well as diagnostics and therapeutic compositions for identifying or treating such issues. Another notable patent involves AGE-1 polypeptides and related molecules. This patent outlines substantially pure AGE-1 polypeptides and purified DNAs, vectors, and cells encoding those polypeptides. It also includes methods for determining longevity and isolating antagonists using the AGE-1 sequence.
Career Highlights
Jason Morris is currently associated with The General Hospital Corporation, where he continues to innovate and develop new solutions in his field. His work is characterized by a commitment to advancing medical science and improving patient outcomes.
Collaborations
Throughout his career, Jason has collaborated with notable colleagues, including Gary B Ruvkun and Heidi Tissenbaum. These partnerships have further enriched his research and development efforts.
Conclusion
In summary, Jason Morris is a prominent inventor whose work in therapeutic and diagnostic tools is paving the way for advancements in treating impaired glucose tolerance conditions. His contributions are invaluable to the medical community and hold promise for future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
